John Peter Wolf III's Net Worth
$6.86 Million
Who is John Peter Wolf III?
John Peter Wolf III has an estimated net worth of $6.86 Million. This is based on reported shares across multiple companies, which include IDERA PHARMACEUTICALS, INC., Nabriva Therapeutics AG, and VIROPHARMA INC.
SEC CIK
John Peter Wolf III's CIK is 0001421915
Past Insider Trading and Trends
2013 was John Peter Wolf III's most active year for acquiring shares with 14 total transactions. John Peter Wolf III's most active month to acquire stocks was the month of December. 2013 was John Peter Wolf III's most active year for disposing of shares, totalling 24 transactions. John Peter Wolf III's most active month to dispose stocks was the month of November. 2013 saw John Peter Wolf III paying a total of $1,468,391.83 for 167,313 shares, this is the most they've acquired in one year. In 2014 John Peter Wolf III cashed out on 388,765 shares for a total of $5,538,400.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IDERA PHARMACEUTICALS, INC. No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.00001
General Counsel and Corp. Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VIROPHARMA INC No price found
VP, General CounselJohn Peter Wolf III used to own units in Common Stock but no longer holds any shares there.acquired a total of 249,140 shares in VIROPHARMA INC at a cost of $2,349,618.68, John also disposed a total of 249,592 shares of VIROPHARMA INC equalling to $9,213,130.31.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -110.77K |
$50.00 |
—
|
0
|
Jan 24
| |||
Form 4
| +170.28% | 69.78K |
$11.39 | $794,816.85 | 110.77K |
Jan 17
| |||
Form 4
| +8,967.04% | 40.53K |
$32.20 | -$1,500,887.21 | 40.98K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
$14.00 | -$390,736.80 |
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
$11.76 | -$228,304.47 |
0
|
Nov 7
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |